S20T (p.Ser20Thr) variant of TP53 (Cellular tumor antigen p53)
S20T (p.Ser20Thr) in TP53 (Cellular tumor antigen p53) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.27 / 1. The record also includes experimental measurements and structural context.
S20T (p.Ser20Thr) variant details
- p.Ser20Thr
- Ensembl rs876659913
- Uncertain significance
- Missense
- Variant Prioritization Score for Impact Estimate 0.267
- ESM-1b 0.00
- AlphaMissense 0.10
- EBI: Variant of uncertain significance
- UniProt: Uncertain significance
- Structural context available
- p53 variant effect measured by cell growth: score -2.78